Business Wire

PA-BENTLEY-SYSTEMS

10.11.2022 22:44:35 CET | Business Wire | Press release

Share
Bentley Systems Enhances SYNCHRO Construction Management Solution with New Capabilities and Applications

Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced advancements to its construction management solution with enhancements to SYNCHRO 4D and the addition of SYNCHRO Cost and SYNCHRO Perform applications. The new advancements and portfolio expansion enable construction firms to transform how they plan, manage, and execute their projects.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221110006078/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Virtual construction, planning, and model-based workflows from the field to office. Image courtesy of Bentley Systems.

“SYNCHRO helps The Lane Construction Corporation have access to all our project-level data. Our field and corporate managers, along with the executives who lead them, now have timely access to critical business information through SYNCHRO,” said Andy Kaiyala, former vice president of bid development, The Lane Construction Corporation. “It is access to this information that helps improve forward-looking decision-making. Our industry has been far too reliant on backward-looking reports and analysis. It is time to start looking ahead and planning for success. SYNCHRO helps us make a plan that we can rely on.”

SYNCHRO 4D now offers advanced 4D/5D model authoring with leading-edge model-splitting tools to create constructible components, assignment of construction attributes to the model, mixed reality modeling, construction geometry placement, and web and mobile access to improve team collaboration, status updates, and progress reporting from the field. The addition of SYNCHRO Cost helps project teams control budgets and track financial progress throughout the contract with support for multicontract capture, payment application tracking, and change order management, minimizing financial risk and maximizing project profits. SYNCHRO Perform enables construction performance management including the ability to capture daily progress quantities, diaries, unplanned events, timesheets, tickets, and estimated field costs to provide the shortest cycle time for project feedback and productivity insights.

Construction firms are striving to deliver more complex projects, address resource gaps and supply chain disruptions, and manage data transparency issues while trying to win more work, manage risk, and deliver profitability. SYNCHRO’s advancements in leveraging 4D/5D models with web access for team collaboration, performance management for progress tracking and reporting, and cost management to minimize risk and maximize profits will transform the way projects are planned and delivered – with digitized workflows to address these challenges.

Leading-edge construction firms are using 4D models to build and optimize schedules and communicate sequencing and staging in a virtual environment. Digital rehearsals are a core part of their planning process to ensure resources are optimized, reducing rework and increasing safety. With the enhancements to SYNCHRO 4D, the accessibility and value of the 4D model is extended to more project stakeholders. The new capabilities improve communication and coordination of optimized plans, enabling real-time collaboration and model-based field-collected data to ensure projects stay on track.

“Construction teams need to ensure that they are in control of both the schedule and costs of their projects,” said Rich Humphrey, vice president of construction at Bentley Systems. “The addition of SYNCHRO Cost and SYNCHRO Perform extends SYNCHRO’s industry leading 4D scheduling and project management solutions to include more capabilities to help contractors manage their costs and effectively connect the planning and tracking of costs and schedule. Time is money and we want project teams to save more of both with SYNCHRO.”

SYNCHRO Cost works with SYNCHRO 4D’s model-based quantity take-off, which includes model splitting to generate constructible components complete with work breakdown structure and cost codes so that estimators can quickly and accurately generate estimates. Moreover, SYNCHRO Cost can control contract changes and simplify payment applications, tracking line items and percentage complete against a schedule of values.

SYNCHRO Cost leverages the performance data in SYNCHRO Perform so project teams can manage and leverage field performance data to gain an accurate picture of actual costs from the field to compare to planned costs and schedule, delivering a complete view of the project’s performance. These digital workflows better connect the office and job site with real-time information. Supplementing contracts and change orders with evidentiary documents and images can prove invaluable in avoiding contract disputes.

With daily, clear line-of-sight into the management of all site resources from staff, sub-contractors, and equipment, SYNCHRO Perform fills the gaps between end-of-month financial reporting cycles. And, with project leadership potentially at a disadvantage when it comes to decision-making due to delays in progress capture and errors in data entry, SYNCHRO Perform provides a timely source of truth for all performance management data and metrics, so that project leadership knows the health of every project. Construction-specific features capture daily progress quantities, diaries, unplanned events, timesheets, tickets, and estimated costs from field personnel, providing leadership with the timely data they need to make informed decisions.

SYNCHRO supports the entire heavy civil construction project lifecycle, empowering firms going digital with real-time insight into the performance, productivity, and financial health of their projects to make more-informed, data-driven decisions. Project teams stay connected and become collaborative with simple mobile and web interfaces for office-to-field workflows.

Image 1:
Caption: Virtual construction, planning, and model-based workflows from the field to office. Image courtesy of Bentley Systems.

Image 2:
Caption: Manage construction contracts, budgets, and change orders. Image courtesy of Bentley Systems.

Image 3:
Caption: Manage construction project performance, progress, and resources. Image courtesy of Bentley Systems.

Get to know SYNCHRO
Video:

https://players.brightcove.net/5209582030001/t50zJOlZh_default/index.html?videoId=6309547476112

Caption: Digital construction management for heavy civil infrastructure projects.

About Bentley Systems

Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, Seequent’s leading geoprofessional software portfolio, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,500 colleagues and generates annual revenues of approximately $1 billion in 186 countries.

www.bentley.com

© 2022 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, ProjectWise, Seequent, SYNCHRO, SYNCHRO 4D, SYNCHRO Control, SYNCHRO Cost, and SYNCHRO Perform are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221110006078/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye